Page last updated: 2024-10-30

metaproterenol and Vascular Diseases

metaproterenol has been researched along with Vascular Diseases in 1 studies

Metaproterenol: A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM.
orciprenaline : A racemate composed of equimolar amounts of (R)- and (S)-orciprenaline. Used (as its sulfate salt) to relax the airway muscles and improve breathing for patients suffering from asthma or bronchitis.
5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol : A member of the class of resorcinols bearing an additional 1-hydroxy-2-(isopropanylamino)ethyl substituent at position 5 of resorcinol itself.

Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strozzi, C1
Cocco, G1
Destro, A1
Padovan, G1
Abbasciano, V1
Tosatti, S1

Other Studies

1 other study available for metaproterenol and Vascular Diseases

ArticleYear
Disorders in peripheral arterial system in asymptomatic elderly: plethysmographic semiology at rest, during postural, effort and pharmacological tests.
    Gerontology, 1979, Volume: 25, Issue:1

    Topics: Aged; Arm; Female; Humans; Male; Metaproterenol; Middle Aged; Nitroglycerin; Physical Exertion; Plet

1979